Not by any objective measure, and you may not have understood how to manage the risk in a start-up bio at the beginning, or managed that risk well. That is a difficult thing, I realize. But not by any measure any more than two people investing in an Apple, despite it being a successful company can have entirely different results in their account. One can do well, another can even lose money on a gaining stock if they don’t know what they are doing.
These stocks are volatile. I am not a licensed advisor, this is just my own experience, but you never invest all at once or early. If you buy early, you buy against a portfolio of other stocks and you manage your price. That is just the nature of microcap bios.
If you bought day one in any bio, unless you sold right away and bought again slowly later, I’d say generally, with drugs still in trials and development, you’ll only do well on an early buyout or partnership, but also again, only if you maintained an average price closer to the lows of that stock than buying at the highs. So you accumulate slowly. Never chase and don’t buy out of fomo.
I don’t know the full story of your buys, but your story is not everyone’s story nor is it really the only or main story of investing NWBO.
Market Data 
Markets 
AI
